Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

SWOG 0819, A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel Or Carboplatin/Paclitaxel/Bevacizumab With Or Without Concurrent Cetuximab i


Collapse Overview 
Collapse sponsor award id
SWOG 0819


Collapse Biography 

Collapse Time 
Collapse start date
2010-05-25